Effects of Disease Type and Latency on the Value of Mortality Risk
33 Pages Posted: 16 Oct 2003 Last revised: 11 Nov 2022
Date Written: October 2003
Abstract
We evaluate the effects of disease type and latency on willingness to pay (WTP) to reduce environmental risks of chronic, degenerative disease. Using contingent-valuation data collected from approximately 1,200 respondents in Taiwan, we find that WTP declines with latency between exposure to environmental contaminants and manifestation of any resulting disease, at a 1.5 percent annual rate for a 20 year latency period. WTP to reduce the risk of cancer is estimated to be about one-third larger than WTP to reduce risk of a similar chronic, degenerative disease. The value of risk reduction also depends on the affected organ, environmental pathway, or payment mechanism: estimated WTP to reduce the risk of lung disease due to industrial air pollution is twice as large as WTP to reduce the risk of liver disease due to contaminated drinking water.
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Are Poor People Worth Less than Rich People? Disaggregating the Value of Statistical Lives
-
By Anna Alberini and Aline Chiabai
-
Paying for Permanence: Public Preferences for Contaminated Site Cleanup
By Anna Alberini, Stefania Tonin, ...
-
Willingness to Pay for Mortality Risk Reductions: Does Latency Matter?
By Anna Alberini, Maureen Cropper, ...
-
Discount Rates in Risk V. Money and Money V. Money Tradeoffs
By Anna Alberini and Aline Chiabai
-
By Anna Alberini, Anil Markandya, ...
-
By Anna Alberini, Stefania Tonin, ...
-
Context and the VSL: Evidence from a Stated Preference Study in Italy and the Czech Republic
By Anna Alberini and Milan ščasný